| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 12/06/2001 | WO2001091780A1 Neuroprotective peptides |
| 12/06/2001 | WO2001091779A1 Remedies for corneal injuries |
| 12/06/2001 | WO2001091774A2 Method of treating chronic ulcers |
| 12/06/2001 | WO2001091773A2 Method of stimulating hair growth |
| 12/06/2001 | WO2001091762A1 Zinc-supplementary compositions for oral administration |
| 12/06/2001 | WO2001091739A2 Compositions and methods for treating neoplastic disease using chemotherapy and radiation sensitizers |
| 12/06/2001 | WO2001091719A1 Nasal ointment based on white petroleum jelly |
| 12/06/2001 | WO2001091713A1 Cosmetic composition comprising human serum albumin obtained from transgenic non-human animals |
| 12/06/2001 | WO2001091711A1 Use of exogenous lactic bacteria strain against actinomyces naeslundii related diseases |
| 12/06/2001 | WO2001091700A2 Composition and method for enhancing elasticity of tissue |
| 12/06/2001 | WO2001091699A2 Compositions and methods for identifying agents which modulate pten function and pi-3 kinase pathways |
| 12/06/2001 | WO2001091698A2 Genetically-engineered mhc molecules |
| 12/06/2001 | WO2001091633A1 A formula to manipulate blood glucose via the calculated ingestion of carbohydrate |
| 12/06/2001 | WO2001091588A1 Primary composition containing a lipophilic bioactive compound |
| 12/06/2001 | WO2001068805A8 Human olfactory receptors and genes encoding same |
| 12/06/2001 | WO2001064922A3 Heterologous expression of neisserial proteins |
| 12/06/2001 | WO2001060837A3 Polypeptoid pulmonary surfactants |
| 12/06/2001 | WO2001060339A3 Method for the preparation of microspheres which contain colloidal systems |
| 12/06/2001 | WO2001057271A8 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human breast and bt 474 cells |
| 12/06/2001 | WO2001056532A3 Neuroprotective, antithrombotic and anti-inflammatory uses of activated protein c (apc) |
| 12/06/2001 | WO2001055387A8 Nucleic acids, proteins, and antibodies |
| 12/06/2001 | WO2001055313A8 Nucleic acids, proteins, and antibodies |
| 12/06/2001 | WO2001053500A8 Methods and materials relating to stem cell growth factor-like poypeptides and polynucleotides |
| 12/06/2001 | WO2001053351A3 Apoptin bindendes protein |
| 12/06/2001 | WO2001052875A8 Vegf-d/vegf-c/vegf peptidomimetic inhibitor |
| 12/06/2001 | WO2001047546A3 Methods and products for tumor immunotherapy using cytokines |
| 12/06/2001 | WO2001046392A3 Homologues of human heparanase and splice variants thereof |
| 12/06/2001 | WO2001046225A3 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 12/06/2001 | WO2001046224A3 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 12/06/2001 | WO2001045732A3 Method and composition for treatment and/or prevention of antibiotic-resistant microorganism infections |
| 12/06/2001 | WO2001044443A3 Cytochrome p450rai-2 and related proteins |
| 12/06/2001 | WO2001041704A3 Method for the prevention and/or treatment of atherosclerosis |
| 12/06/2001 | WO2001034646A3 Recombinant gelatins |
| 12/06/2001 | WO2001034181A3 Methods of treating short stature disorders related to the short stature homeobox-containing (shox) gene |
| 12/06/2001 | WO2001034138B1 Compositions and methods for treatment of neurological disorders and neurodegenerative diseases |
| 12/06/2001 | WO2001030991A3 Human narcolepsy gene |
| 12/06/2001 | WO2001030854A3 Antibody to human gastrointestinal epithelial tumor antigen related to alpha 6 beta 4 integrin |
| 12/06/2001 | WO2001030376A3 Use of urodilatin for treating chronic kidney failure with residual kidney functions |
| 12/06/2001 | WO2001025390B1 Water unstable foam compositions |
| 12/06/2001 | WO2001025257A3 Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery |
| 12/06/2001 | WO2001023553A9 Metastasis-associated antigen c4.4a |
| 12/06/2001 | WO2001023421B1 Stress protein compositions and methods for prevention and treatment of cancer and infectious disease |
| 12/06/2001 | WO2001021653A3 Ovarian tumor antigen and methods of use therefor |
| 12/06/2001 | WO2001018042A3 Apoptosis proteins |
| 12/06/2001 | WO2001016345A3 Sequence-specific dna recombination in eukaryotic cells |
| 12/06/2001 | WO2001012775A8 25 human secreted proteins |
| 12/06/2001 | WO2001012662A3 Membrane associated proteins |
| 12/06/2001 | WO2001005432A3 Conjugate for mediating cell, compartment or membrane-specific transport of active substances |
| 12/06/2001 | WO2000072868A3 Peptides for therapeutic use |
| 12/06/2001 | WO2000050443A9 Secreted proteins and uses thereof |
| 12/06/2001 | WO2000038517A9 Methods for reducing adverse side effects associated with cellular transplantation |
| 12/06/2001 | WO2000025804A9 A method for inhibition of phospholamban activity for the treatment of cardiac disease and heart failure |
| 12/06/2001 | WO2000011166A9 14274 receptor, a g-protein coupled receptor related to the edg receptor family |
| 12/06/2001 | WO2000011036A9 AN ANTI-CYANOVIRIN ANTIBODY WITH AN INTERNAL IMAGE OF gp120, A METHOD OF USE THEREOF, AND A METHOD OF USING A CYANOVIRIN TO INDUCE AN IMMUNE RESPONSE TO gp120 |
| 12/06/2001 | WO2000006599A8 Inhibitors of hiv membrane fusion |
| 12/06/2001 | WO1997017448A3 Calcium independent cytosolic phospholipase a2/b enzymes |
| 12/06/2001 | US20010049829 Developmental competence for assisted reproduction and nuclear transfer in pigs |
| 12/06/2001 | US20010049359 Treatment of hiv infection |
| 12/06/2001 | US20010049357 Promotes dendritic cell maturation in vitro. |
| 12/06/2001 | US20010049356 Method of preparing fetuin to induce apoptosis |
| 12/06/2001 | US20010049355 Providing exogenous SLED to endothelial cells; maybe be provided systemically, topically, or via a vector comprising a SLED expression cassette |
| 12/06/2001 | US20010049354 Protecting solid-state proteins from the effects of ionizing radiation |
| 12/06/2001 | US20010049353 Stimulating secretion of pancreatic juices |
| 12/06/2001 | US20010049352 Hydrolyzed whey protein; a carbohydrate source; and a lipid source including a mixture of medium and long chain triglycerides; caloric density of at least 1.4 kcal/mL; ratio of non-protein calories per gram nitrogen of at least 90:1. |
| 12/06/2001 | US20010049351 Method of determining down-regulation of the expression of hiv coreceptor, ccr5 with product r |
| 12/06/2001 | US20010049349 Antioxidant enhancement of therapy for hyperproliferative conditions |
| 12/06/2001 | US20010049142 A rapid, simple-to-use method to differentiate nondividing cells by fusing two different cells and then purifying them without antibiotic or metabolic selection; kits with two nontoxic dyes and instructions; antitumor agents |
| 12/06/2001 | US20010049136 Deletion of: all or part of the E1A regions, the E1B region coding for the early proteins, E2 or E4 regions, the E1a region and encapsidation region; gene therapy |
| 12/06/2001 | US20010049122 For reducing inflammation, for treating an autoimmune disease, for enhancing transplantation of tissue grafts, increasing antitumor immunity, and inhibiting viral and parasitic infections |
| 12/06/2001 | US20010049121 Polypeptides and polynucleotides; drug screening, use in therapy, diagnostic assays |
| 12/06/2001 | US20010049107 Patient-specific library of antineoplastic antibodies or fragments; variable regions are linked, cloned into expression vectors, amplified; libraries transferred to other expression vectors without losing diversity |
| 12/06/2001 | US20010049106 ADAM (A Disintegrin And Metalloprotease) family of metalloproteases, and in addition contain thrombospondin domain (TS); treating diabetes, arthritis, cancer, solid tumors, autoimmune diseases |
| 12/06/2001 | US20010049093 Inhibition of viral gene activities |
| 12/06/2001 | US20010048952 Mixture of aloe vera, collagen, chromium compounds and linoleic acid |
| 12/06/2001 | US20010048948 Intestine health; immunology; mixture containing whey |
| 12/06/2001 | US20010048947 Drug delivery |
| 12/06/2001 | US20010048925 Core or carrier adjuvant for vaccine |
| 12/06/2001 | US20010048924 Method for inhibiting cerebral tissue factor mediated reperfusion damage |
| 12/06/2001 | US20010048923 Immune cell regulation with src ptk sequestering agents |
| 12/06/2001 | US20010048915 Decreased endogenous nitric oxide activation |
| 12/06/2001 | DE10025464A1 Kombinierte Verwendung von Enzyminhibitoren zur Therapie von Autoimmunerkrankungen, bei Transplantationen und Tumorerkrankungen sowie Kombinationen von Enzyminhibitoren umfassende pharmazeutische Zubereitungen Combined use of enzyme inhibitors for the therapy of autoimmune diseases, transplantation and tumor diseases as well as combinations of enzyme inhibitors pharmaceutical preparations comprising |
| 12/06/2001 | DE10025152A1 Treatment of noise- or age-induced hearing deficiency, comprises using neurotrophin stimulating agents to counteract cochlear neurodegeneration |
| 12/06/2001 | CA2415225A1 Composition and method for enhancing elasticity of tissue |
| 12/06/2001 | CA2414207A1 Adjuvant preparation for the induction of specific immunity |
| 12/06/2001 | CA2413188A1 Petrolatum-based nose ointment |
| 12/06/2001 | CA2411667A1 Ghrelin analogs |
| 12/06/2001 | CA2411666A1 Methods and compositions for producing a neurosalutary effect in a subject |
| 12/06/2001 | CA2411404A1 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 12/06/2001 | CA2411040A1 Therapeutic anti-melanoma compounds |
| 12/06/2001 | CA2410981A1 Adenovirus particles with mutagenized fiber proteins |
| 12/06/2001 | CA2410949A1 Novel target genes for diseases of the heart |
| 12/06/2001 | CA2410912A1 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof |
| 12/06/2001 | CA2410895A1 Therapeutic compounds for ovarian cancer |
| 12/06/2001 | CA2410865A1 Therapeutic compounds for ovarian cancer |
| 12/06/2001 | CA2410762A1 Feline hepatocyte growth factor |
| 12/06/2001 | CA2410758A1 Use of acrp30 globular head to promote increases in muscle mass and muscle differentiation |
| 12/06/2001 | CA2410736A1 Alpha (2) macroglobulin receptors as a heat shock protein receptor and uses thereof |
| 12/06/2001 | CA2410735A1 Use of adnf for enhancing learning and memory |
| 12/06/2001 | CA2410591A1 Use of exogenous lactic bacteria strain against actinomyces naeslundii related diseases |
| 12/06/2001 | CA2410523A1 Targeted chromosomal genomic alterations in plants using modified single stranded oligonucleotides |